Ontology highlight
ABSTRACT: Objective
To evaluate harms and benefits associated with use of combined hormone replacement therapy (HRT) for five years in women with different baseline risks for breast cancer.Design
Probabilistic clinical decision analysis.Setting
Hypothetical population of white UK women aged 50 years with different baseline risks for breast cancer.Main outcome measure
Gain or loss in quality adjusted life years (QALYs).Results
Women free of menopausal symptoms showed a net harm from HRT use, which increased for increasing baseline risk of breast cancer. Those with a baseline risk of 1.2% would expect a loss in QALYs of 0.4 months (- 0.03 QALYs, 95% credibility interval - 0.05 to - 0.01). The main analysis showed HRT to be on average beneficial in women with sym
SUBMITTER: Minelli C
PROVIDER: S-EPMC341383 | biostudies-literature | 2004 Feb
REPOSITORIES: biostudies-literature